Inactivated Polio Vaccine and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Inactivated Polio Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inactivated Polio Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inactivated Polio Vaccine Overall Market Size
2.1 Global Inactivated Polio Vaccine Market Size: 2022 VS 2030
2.2 Global Inactivated Polio Vaccine Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Inactivated Polio Vaccine Sales: 2018-2030
3 Company Landscape
3.1 Top Inactivated Polio Vaccine Players in Global Market
3.2 Top Global Inactivated Polio Vaccine Companies Ranked by Revenue
3.3 Global Inactivated Polio Vaccine Revenue by Companies
3.4 Global Inactivated Polio Vaccine Sales by Companies
3.5 Global Inactivated Polio Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Inactivated Polio Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Inactivated Polio Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Inactivated Polio Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Inactivated Polio Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Inactivated Polio Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Inactivated Polio Vaccine Market Size Markets, 2022 & 2030
4.1.2 Government
4.1.3 Private Sector
4.2 By Type - Global Inactivated Polio Vaccine Revenue & Forecasts
4.2.1 By Type - Global Inactivated Polio Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Inactivated Polio Vaccine Revenue, 2024-2030
4.2.3 By Type - Global Inactivated Polio Vaccine Revenue Market Share, 2018-2030
4.3 By Type - Global Inactivated Polio Vaccine Sales & Forecasts
4.3.1 By Type - Global Inactivated Polio Vaccine Sales, 2018-2023
4.3.2 By Type - Global Inactivated Polio Vaccine Sales, 2024-2030
4.3.3 By Type - Global Inactivated Polio Vaccine Sales Market Share, 2018-2030
4.4 By Type - Global Inactivated Polio Vaccine Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inactivated Polio Vaccine Market Size, 2022 & 2030
5.1.2 Pediatrics
5.1.3 Adults
5.2 By Application - Global Inactivated Polio Vaccine Revenue & Forecasts
5.2.1 By Application - Global Inactivated Polio Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Inactivated Polio Vaccine Revenue, 2024-2030
5.2.3 By Application - Global Inactivated Polio Vaccine Revenue Market Share, 2018-2030
5.3 By Application - Global Inactivated Polio Vaccine Sales & Forecasts
5.3.1 By Application - Global Inactivated Polio Vaccine Sales, 2018-2023
5.3.2 By Application - Global Inactivated Polio Vaccine Sales, 2024-2030
5.3.3 By Application - Global Inactivated Polio Vaccine Sales Market Share, 2018-2030
5.4 By Application - Global Inactivated Polio Vaccine Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Inactivated Polio Vaccine Market Size, 2022 & 2030
6.2 By Region - Global Inactivated Polio Vaccine Revenue & Forecasts
6.2.1 By Region - Global Inactivated Polio Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Inactivated Polio Vaccine Revenue, 2024-2030
6.2.3 By Region - Global Inactivated Polio Vaccine Revenue Market Share, 2018-2030
6.3 By Region - Global Inactivated Polio Vaccine Sales & Forecasts
6.3.1 By Region - Global Inactivated Polio Vaccine Sales, 2018-2023
6.3.2 By Region - Global Inactivated Polio Vaccine Sales, 2024-2030
6.3.3 By Region - Global Inactivated Polio Vaccine Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Inactivated Polio Vaccine Revenue, 2018-2030
6.4.2 By Country - North America Inactivated Polio Vaccine Sales, 2018-2030
6.4.3 US Inactivated Polio Vaccine Market Size, 2018-2030
6.4.4 Canada Inactivated Polio Vaccine Market Size, 2018-2030
6.4.5 Mexico Inactivated Polio Vaccine Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Inactivated Polio Vaccine Revenue, 2018-2030
6.5.2 By Country - Europe Inactivated Polio Vaccine Sales, 2018-2030
6.5.3 Germany Inactivated Polio Vaccine Market Size, 2018-2030
6.5.4 France Inactivated Polio Vaccine Market Size, 2018-2030
6.5.5 U.K. Inactivated Polio Vaccine Market Size, 2018-2030
6.5.6 Italy Inactivated Polio Vaccine Market Size, 2018-2030
6.5.7 Russia Inactivated Polio Vaccine Market Size, 2018-2030
6.5.8 Nordic Countries Inactivated Polio Vaccine Market Size, 2018-2030
6.5.9 Benelux Inactivated Polio Vaccine Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Inactivated Polio Vaccine Revenue, 2018-2030
6.6.2 By Region - Asia Inactivated Polio Vaccine Sales, 2018-2030
6.6.3 China Inactivated Polio Vaccine Market Size, 2018-2030
6.6.4 Japan Inactivated Polio Vaccine Market Size, 2018-2030
6.6.5 South Korea Inactivated Polio Vaccine Market Size, 2018-2030
6.6.6 Southeast Asia Inactivated Polio Vaccine Market Size, 2018-2030
6.6.7 India Inactivated Polio Vaccine Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Inactivated Polio Vaccine Revenue, 2018-2030
6.7.2 By Country - South America Inactivated Polio Vaccine Sales, 2018-2030
6.7.3 Brazil Inactivated Polio Vaccine Market Size, 2018-2030
6.7.4 Argentina Inactivated Polio Vaccine Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Inactivated Polio Vaccine Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Inactivated Polio Vaccine Sales, 2018-2030
6.8.3 Turkey Inactivated Polio Vaccine Market Size, 2018-2030
6.8.4 Israel Inactivated Polio Vaccine Market Size, 2018-2030
6.8.5 Saudi Arabia Inactivated Polio Vaccine Market Size, 2018-2030
6.8.6 UAE Inactivated Polio Vaccine Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Inactivated Polio Vaccine Major Product Offerings
7.1.4 Sanofi Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Inactivated Polio Vaccine Major Product Offerings
7.2.4 GSK Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Bibcol
7.3.1 Bibcol Company Summary
7.3.2 Bibcol Business Overview
7.3.3 Bibcol Inactivated Polio Vaccine Major Product Offerings
7.3.4 Bibcol Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Bibcol Key News & Latest Developments
7.4 Serum Institute
7.4.1 Serum Institute Company Summary
7.4.2 Serum Institute Business Overview
7.4.3 Serum Institute Inactivated Polio Vaccine Major Product Offerings
7.4.4 Serum Institute Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Serum Institute Key News & Latest Developments
7.5 Tiantan Biological
7.5.1 Tiantan Biological Company Summary
7.5.2 Tiantan Biological Business Overview
7.5.3 Tiantan Biological Inactivated Polio Vaccine Major Product Offerings
7.5.4 Tiantan Biological Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Tiantan Biological Key News & Latest Developments
7.6 Panacea Biotec
7.6.1 Panacea Biotec Company Summary
7.6.2 Panacea Biotec Business Overview
7.6.3 Panacea Biotec Inactivated Polio Vaccine Major Product Offerings
7.6.4 Panacea Biotec Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Panacea Biotec Key News & Latest Developments
7.7 Bio-Med
7.7.1 Bio-Med Company Summary
7.7.2 Bio-Med Business Overview
7.7.3 Bio-Med Inactivated Polio Vaccine Major Product Offerings
7.7.4 Bio-Med Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Bio-Med Key News & Latest Developments
7.8 Halfkin Bio-Pharmaceuticals
7.8.1 Halfkin Bio-Pharmaceuticals Company Summary
7.8.2 Halfkin Bio-Pharmaceuticals Business Overview
7.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Major Product Offerings
7.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Inactivated Polio Vaccine Production Capacity, Analysis
8.1 Global Inactivated Polio Vaccine Production Capacity, 2018-2030
8.2 Inactivated Polio Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Inactivated Polio Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Inactivated Polio Vaccine Supply Chain Analysis
10.1 Inactivated Polio Vaccine Industry Value Chain
10.2 Inactivated Polio Vaccine Upstream Market
10.3 Inactivated Polio Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Inactivated Polio Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Inactivated Polio Vaccine in Global Market
Table 2. Top Inactivated Polio Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Inactivated Polio Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Inactivated Polio Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Inactivated Polio Vaccine Sales by Companies, (K Dose), 2018-2023
Table 6. Global Inactivated Polio Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Inactivated Polio Vaccine Price (2018-2023) & (US$/Dose)
Table 8. Global Manufacturers Inactivated Polio Vaccine Product Type
Table 9. List of Global Tier 1 Inactivated Polio Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inactivated Polio Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Inactivated Polio Vaccine Sales (K Dose), 2018-2023
Table 15. By Type - Global Inactivated Polio Vaccine Sales (K Dose), 2024-2030
Table 16. By Application ? Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Inactivated Polio Vaccine Sales (K Dose), 2018-2023
Table 20. By Application - Global Inactivated Polio Vaccine Sales (K Dose), 2024-2030
Table 21. By Region ? Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Inactivated Polio Vaccine Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Inactivated Polio Vaccine Sales (K Dose), 2018-2023
Table 25. By Region - Global Inactivated Polio Vaccine Sales (K Dose), 2024-2030
Table 26. By Country - North America Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Inactivated Polio Vaccine Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Inactivated Polio Vaccine Sales, (K Dose), 2018-2023
Table 29. By Country - North America Inactivated Polio Vaccine Sales, (K Dose), 2024-2030
Table 30. By Country - Europe Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Inactivated Polio Vaccine Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Inactivated Polio Vaccine Sales, (K Dose), 2018-2023
Table 33. By Country - Europe Inactivated Polio Vaccine Sales, (K Dose), 2024-2030
Table 34. By Region - Asia Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Inactivated Polio Vaccine Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Inactivated Polio Vaccine Sales, (K Dose), 2018-2023
Table 37. By Region - Asia Inactivated Polio Vaccine Sales, (K Dose), 2024-2030
Table 38. By Country - South America Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Inactivated Polio Vaccine Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Inactivated Polio Vaccine Sales, (K Dose), 2018-2023
Table 41. By Country - South America Inactivated Polio Vaccine Sales, (K Dose), 2024-2030
Table 42. By Country - Middle East & Africa Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Inactivated Polio Vaccine Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Inactivated Polio Vaccine Sales, (K Dose), 2018-2023
Table 45. By Country - Middle East & Africa Inactivated Polio Vaccine Sales, (K Dose), 2024-2030
Table 46. Sanofi Company Summary
Table 47. Sanofi Inactivated Polio Vaccine Product Offerings
Table 48. Sanofi Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. GSK Company Summary
Table 51. GSK Inactivated Polio Vaccine Product Offerings
Table 52. GSK Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 53. GSK Key News & Latest Developments
Table 54. Bibcol Company Summary
Table 55. Bibcol Inactivated Polio Vaccine Product Offerings
Table 56. Bibcol Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 57. Bibcol Key News & Latest Developments
Table 58. Serum Institute Company Summary
Table 59. Serum Institute Inactivated Polio Vaccine Product Offerings
Table 60. Serum Institute Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 61. Serum Institute Key News & Latest Developments
Table 62. Tiantan Biological Company Summary
Table 63. Tiantan Biological Inactivated Polio Vaccine Product Offerings
Table 64. Tiantan Biological Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 65. Tiantan Biological Key News & Latest Developments
Table 66. Panacea Biotec Company Summary
Table 67. Panacea Biotec Inactivated Polio Vaccine Product Offerings
Table 68. Panacea Biotec Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 69. Panacea Biotec Key News & Latest Developments
Table 70. Bio-Med Company Summary
Table 71. Bio-Med Inactivated Polio Vaccine Product Offerings
Table 72. Bio-Med Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 73. Bio-Med Key News & Latest Developments
Table 74. Halfkin Bio-Pharmaceuticals Company Summary
Table 75. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Offerings
Table 76. Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales (K Dose), Revenue (US$, Mn) and Average Price (US$/Dose) (2018-2023)
Table 77. Halfkin Bio-Pharmaceuticals Key News & Latest Developments
Table 78. Inactivated Polio Vaccine Production Capacity (K Dose) of Key Manufacturers in Global Market, 2021-2023 (K Dose)
Table 79. Global Inactivated Polio Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Inactivated Polio Vaccine Production by Region, 2018-2023 (K Dose)
Table 81. Global Inactivated Polio Vaccine Production by Region, 2024-2030 (K Dose)
Table 82. Inactivated Polio Vaccine Market Opportunities & Trends in Global Market
Table 83. Inactivated Polio Vaccine Market Drivers in Global Market
Table 84. Inactivated Polio Vaccine Market Restraints in Global Market
Table 85. Inactivated Polio Vaccine Raw Materials
Table 86. Inactivated Polio Vaccine Raw Materials Suppliers in Global Market
Table 87. Typical Inactivated Polio Vaccine Downstream
Table 88. Inactivated Polio Vaccine Downstream Clients in Global Market
Table 89. Inactivated Polio Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Inactivated Polio Vaccine Segment by Type in 2022
Figure 2. Inactivated Polio Vaccine Segment by Application in 2022
Figure 3. Global Inactivated Polio Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Inactivated Polio Vaccine Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Inactivated Polio Vaccine Revenue, 2018-2030 (US$, Mn)
Figure 7. Inactivated Polio Vaccine Sales in Global Market: 2018-2030 (K Dose)
Figure 8. The Top 3 and 5 Players Market Share by Inactivated Polio Vaccine Revenue in 2022
Figure 9. By Type - Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 11. By Type - Global Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 12. By Type - Global Inactivated Polio Vaccine Price (US$/Dose), 2018-2030
Figure 13. By Application - Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 15. By Application - Global Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 16. By Application - Global Inactivated Polio Vaccine Price (US$/Dose), 2018-2030
Figure 17. By Region - Global Inactivated Polio Vaccine Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Inactivated Polio Vaccine Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 20. By Region - Global Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 21. By Country - North America Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 22. By Country - North America Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 23. US Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 28. Germany Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 29. France Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 37. China Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 41. India Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 43. By Country - South America Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 44. Brazil Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Inactivated Polio Vaccine Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Inactivated Polio Vaccine Sales Market Share, 2018-2030
Figure 48. Turkey Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Inactivated Polio Vaccine Revenue, (US$, Mn), 2018-2030
Figure 52. Global Inactivated Polio Vaccine Production Capacity (K Dose), 2018-2030
Figure 53. The Percentage of Production Inactivated Polio Vaccine by Region, 2022 VS 2030
Figure 54. Inactivated Polio Vaccine Industry Value Chain
Figure 55. Marketing Channels